about
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphomaNon random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements.ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia.Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemiaTP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing.Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemiaLymphoid enhancer binding factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia.Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology.SETBP1 dysregulation in congenital disorders and myeloid neoplasms.BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR.MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32).Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia.Gene expression profiling of chronic myeloid leukemia with variant t(9;22) reveals a different signature from cases with classic translocation.Systemic Mastocytosis with Associated Chronic Lymphocytic Leukemia: A Matter of Diseases or Prognostic Factors?5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications.A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia.SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemiaDroplet digital PCR assay for quantifying of CALR mutant allelic burden in myeloproliferative neoplasms.Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology.A novel t(3;9)(q21.2; p24.3) associated with SMARCA2 and ZNF148 genes rearrangement in myelodysplastic syndrome.Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3.Genomic BCR-ABL1 breakpoint characterization by a multi-strategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients.Decreased TET2 gene expression during chronic myeloid leukemia progression.IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house.Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemiaThe double deceit generated by an insertion mechanism in chronic myeloid leukemia with t(9;9;22)Centromeric fragment of chromosome 7 in atypical chronic myeloid leukemia with the SET binding protein 1 gene mutationMyelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265PBCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation?A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene
P50
Q33761711-4D10D7CF-5D16-4004-83B7-5136C07C6B5BQ33919931-91433CCD-294C-4859-A10A-ADCEF6CBCD7AQ35525365-8C00E57D-4F62-4A83-B8DF-44AF30F116DDQ35955272-18ECD8E7-EB22-4BA7-8FE3-4D7032864475Q37326100-1FC8E546-1272-4698-9CDF-F1ED4F0681BEQ37699259-8B90602B-3792-404F-8837-B2D2BCAB066BQ37718455-63C2338B-A11D-4882-8BB3-106AD4C9EA88Q38701790-78A12213-0BA5-4CC7-A970-5E60D44EEFCEQ39284252-3CA60E4B-8758-4B55-B87D-169CBF3055B3Q40294208-3263C7E4-5C22-4800-AE63-710CADF1E219Q40391981-C5469B56-C590-4BFC-9909-C064AA458D76Q40449249-610F859A-AF19-4F01-AEDF-F99392BB57EAQ40856474-D046FF0F-F6EA-4D38-9352-D96E58635E61Q41253739-3DF38FD6-D428-410C-8263-DDDBA27FBF51Q41789671-D3DE2F89-2173-411D-B184-7FC6F540E74AQ42277656-CDCA077F-DCC6-45EC-BB3A-19A88C75DD5EQ42426547-820DFDC9-8EA0-457D-B437-A17307775888Q43670993-3114F09E-53B0-40D0-BECC-9036DAB1569FQ45740186-153C3639-44BD-4E09-BDC2-0718D94B4EB3Q48109687-CABF79EF-ED9D-47CD-B9EC-51DA12C95B36Q50563203-5FA0E98F-F61F-4A48-93D6-79BD2E2FEE9CQ52355106-AD6FAF99-42ED-4160-8C41-F7B2A7FE032CQ54357058-DACBC8E8-DA78-4164-AB20-8D4CCBA28EEFQ54385419-9B4C15C8-1577-43E4-85C5-36BB733FFCB6Q57690149-94654BDC-7BF7-45D1-8561-6B53C11B07C3Q57690201-827A2600-C215-4386-98CA-64E5FECE8210Q59547203-E421B2C9-93C2-45BD-8FB1-D8EC11F9C6FAQ59547220-8CA74290-B1B6-4EF5-AEA3-132D0EC6F976Q59547295-3612367A-05D9-495E-A495-D6C2F6AD388EQ59547371-E7CF2009-DF96-47A0-BA3C-3269F12C8FC3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nicoletta Coccaro
@ast
Nicoletta Coccaro
@en
Nicoletta Coccaro
@es
Nicoletta Coccaro
@nl
type
label
Nicoletta Coccaro
@ast
Nicoletta Coccaro
@en
Nicoletta Coccaro
@es
Nicoletta Coccaro
@nl
prefLabel
Nicoletta Coccaro
@ast
Nicoletta Coccaro
@en
Nicoletta Coccaro
@es
Nicoletta Coccaro
@nl
P106
P1153
24340917800
P31
P496
0000-0003-1327-8186